Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program
Clinical trial NCT05066685 · COMPLETED
Trial details
- NCT number
- NCT05066685
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-11
- Primary completion
- 2020-09-25
- Enrollment
- 18457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.